Lataa...
Entering the spotlight: hepatitis B surface antigen–specific B cells
Hepatitis B virus–specific (HBV-specific) T cells have been identified as main effector cells in HBV clearance. In contrast, B cells producing neutralizing antibodies against the HBV surface antigen (HBsAg) have been studied in little detail, mainly due to methodical limitations. In this issue of th...
Tallennettuna:
| Julkaisussa: | J Clin Invest |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Clinical Investigation
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6159969/ https://ncbi.nlm.nih.gov/pubmed/30222139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI124098 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|